Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda

Clin Infect Dis. 2020 Dec 3;71(9):2497-2499. doi: 10.1093/cid/ciaa261.

Abstract

Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All" in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.

Keywords: CD4; HIV; opportunistic infections; test-and-treat; treat all.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • HIV
  • HIV Infections* / diagnosis
  • HIV Infections* / drug therapy
  • Humans
  • Uganda / epidemiology